Cargando…
A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone
RATIONALE: Myasthenia gravis (MG) patients are at increased risk of COVID-19 infection and its complications due to chronic immunosuppression. COVID-19 infection can also increase the risk of myasthenia exacerbation. PATIENT CONCERNS: The patient presented with respiratory distress, fever and chills...
Autores principales: | Bhagavan, Sachin M., Ramaswamy, Swathi Beladakere, Govindarajan, Raghav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104252/ https://www.ncbi.nlm.nih.gov/pubmed/33950951 http://dx.doi.org/10.1097/MD.0000000000025701 |
Ejemplares similares
-
COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
por: Ramaswamy, Swathi Beladakere, et al.
Publicado: (2020) -
Recurrent Opportunistic Infections in a Thymectomised Patient with Myasthenia Gravis and Good’s Syndrome
por: Shankar Kikkeri, Nidhi, et al.
Publicado: (2018) -
Brachial plexopathy with Sjögren syndrome
por: Bhagavan, Sachin M., et al.
Publicado: (2019) -
A 62-Year-Old Man Presenting with Bilateral Tremor of the Upper Limb After a Diagnosis of COVID-19 with Confirmed Volumetric Brain Loss
por: Bhagavan, Sachin M., et al.
Publicado: (2022) -
Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis
por: Tayebi, Amir Hossein, et al.
Publicado: (2023)